Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage 2 Diastolic Hypertension”

16 trials

Showing 16 of 16 results

Post-approval studies (Phase 4)Study completedNCT01218100
What this trial is testing

Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension

Who this might be right for
Stage 2 Diastolic Hypertension
Forest Laboratories 664
Large-scale testing (Phase 3)Study completedNCT00350168
What this trial is testing

Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension

Who this might be right for
Hypertension
Novartis 647
Post-approval studies (Phase 4)Study completedNCT00942994
What this trial is testing

Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension

Who this might be right for
Hypertension
Novartis 412
Post-approval studies (Phase 4)Study completedNCT00760266
What this trial is testing

Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population

Who this might be right for
Hypertension
Novartis 451
Post-approval studies (Phase 4)Study completedNCT00739596
What this trial is testing

Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans

Who this might be right for
Hypertension
Novartis Pharmaceuticals 332
Testing effectiveness (Phase 2)Study completedNCT00759551
What this trial is testing

Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension

Who this might be right for
Hypertension
Takeda 555
Post-approval studies (Phase 4)Study completedNCT00853957
What this trial is testing

Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension

Who this might be right for
Hypertension
Novartis 443
Post-approval studies (Phase 4)Study completedNCT00787605
What this trial is testing

Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus

Who this might be right for
HypertensionDiabetes Mellitus
Novartis 860
Post-approval studies (Phase 4)Study completedNCT00772577
What this trial is testing

Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension

Who this might be right for
Hypertension
Novartis 386
Post-approval studies (Phase 4)Study completedNCT00797316
What this trial is testing

Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension

Who this might be right for
Hypertension
Novartis 532
Testing effectiveness (Phase 2)Study completedNCT00362115
What this trial is testing

Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension

Who this might be right for
Hypertension
Takeda 449
Large-scale testing (Phase 3)Ended earlyNCT00376181
What this trial is testing

Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Takeda 96
Testing effectiveness (Phase 2)Study completedNCT03928158
What this trial is testing

LCZ696 in Advanced LV Hypertrophy and HFpEF

Who this might be right for
Heart FailureEssential Hypertension
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 61
Post-approval studies (Phase 4)Study completedNCT00927394
What this trial is testing

Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus

Who this might be right for
Hypertension
Novartis 1,143
Testing effectiveness (Phase 2)WithdrawnNCT07221513
What this trial is testing

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

Who this might be right for
HFrEF - Heart Failure With Reduced Ejection FractionHFpEF - Heart Failure With Preserved Ejection FractionGroup 2 Pulmonary Hypertension
Salubris Biotherapeutics Inc
Large-scale testing (Phase 3)Study completedNCT00353912
What this trial is testing

Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension

Who this might be right for
Hypertension
Novartis 571

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation